Brought to you by Nuclear Education Online (NEO)                    Volume 1, No. 4              May 2003

UNM Radiopharmacy Celebrates 30th Anniversary
1973-2003 The University of New Mexico's Radiopharmacy Program is celebrating the 30th Anniversary this year. 
For more information and photos...
 
Generic Strontium-89 Available
Miami, May 21, 2003 – Bio-Nucleonics Pharma, Inc. announced that it has received U.S. Food and Drug Administration approval for Strontium Chloride Sr-89 Injection USP, a radiopharmaceutical that offers pain relief for patients with breast, prostate or lung cancer that has metastasized or spread to bone.
More Medicare Coverage for PET Imaging
Medicare will now cover PET imaging for staging of follicular thyroid cancer previously treated by thryroidectomy and I-131 ablation with an elevated thryroglobulin > 10 ng/ml and negative I-131 whole body scan.  They also announced coverage of N-13 ammonia PET for myocardial perfusion.  The complete CMS decision memos can be found at:
http://www.cms.hhs.gov/ncdr/memo.asp?id=70
http://www.cms.hhs.gov/ncdr/memo.asp?id=66
 
FPA Looking for Speakers
The Florida Pharmacy Association is looking for speakers for their APP Mid-Year Clinical Conference at the Radisson Downtown Orlando on Nov. 15-16, 2003.  The Nuclear Track will include 12 hours of nuclear CE, 1 hour of AIDS review, and 2 hours for Medication Errors.  Contact Cecilia Kemmer if you are interested in being a speaker.

May 31 Excellence in PET Imaging: Read with the PET Experts; Lisle, IL hosted by SNM
June 2-4 Imaging in Drug Discovery & Development: Advances in Non-Invasive Imaging Applications and Technology ; Vienna, VA
June 21-25 SNM 50th Annual Meeting, New Orleans
July 1-5 Emory University School of Medicine 17th Annual Nuclear Medicine Update Course  The Cloister; Sea Island, Georgia
August 10-14 15th International Symposium on Radiopharmaceutical Chemistry (ISRC)    Sydney, Australia
August 15-18 Second Annual Meeting of the Society for Molecular Imaging San Francisco, CA
August 23-27 European Society of Nuclear Medicine   Amsterdam
Sept. 11-14 ASNC American Society of Nuclear Cardiology; Indianapolis, IN


In 1968 Henry Wagner Jr., MD and his colleagues at Johns Hopkins Institution in Baltimore studied the use of radiolabeled albumin for imaging pulmonary embolism.  The first studies were on laboratory animals with experimental PE.  After studies demonstrated that it would be safe to administer to humans Dr. Wagner was so confident in their results that he was the first volunteer for the lung perfusion study.  He went on to study the use of Xenon-133 for ventilation imaging. We could say that Henry Wagner is the "Father of the VQ Scan".



A 73 year old black female presented with chief complaint of nausea, vomiting and weakness.  Past history of breast cancer and hypothyroidism.  Continued....

 

Brought to you by
 

© 2003 Nuclear Education Online
4301 W. Markham #522
Little Rock, AR  72205
501-686-6398
For more information, contact Nicki Hilliard.

To subscribe to this mailing list click here.

 If this email does not view graphics properly go to http://www.nuclearonline.org/newsletter/May03.htm